Rush University Medical Center; Div of Hematology
1653 West Congress Parkway
Chicago, Illinois 60612

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Breast Cancer Clinical Trial
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Rush University Medical Center; Div of Hematology
mi
from
Chicago, IL
Click here to add this to my saved trials